Publications by authors named "İbrahim Basol"
Article Synopsis
- The study aimed to assess the impact of botulinum toxin-A (BTX-A) on corneal and ocular metrics in patients with benign essential blepharospasm (BEB) and hemifacial spasm (HFS).
- Researchers analyzed data from 66 eyes of 33 BEB patients and 5 eyes of 5 HFS patients, focusing on various measurements before and after BTX-A treatment one month later.
- Results indicated significant changes in corneal power, anterior chamber depth, and a decrease in expected intraocular lens power using several calculation formulas, suggesting that BTX-A may influence eye measurements post-treatment.
Purpose: we aimed to report on the optical coherence tomography angiography (OCTA) outcomes of eight patients with optic disc pit maculopathy (ODP-M) who were treated with 23-gauge pars plana vitrectomy (PPV).
Methods: We examined sixteen eyes of eight patients-eight eyes with ODP-M and eight healthy fellow eyes. Fundus color photography, fundus autofluorescence, fundus fluorescein angiography, optical coherence tomography (OCT), and OCTA were performed.
Aim: To investigate the choroidal thickness and the microvascular network changes around the macula in thyroid eye disease (TED) patients at different stages and the relationship of those changes with risk factors, serum antibodies and the severity of TED.
Methods: A total of 85 participants were enrolled. All participants underwent ophthalmology and endocrinology examinations.
Purpose: We aim to contribute to the literature in terms of treatment safety with our real world data by examining the anterior segment complications and follow-up results of patients who underwent dexamethasone implants in our clinic.
Methods: The records of patients treated with at least one intravitreal dexamethasone implant for various retinal diseases: diabetic macular edema (265 eyes), central retinal vein occlusion (45 eyes), retinal vein branch occlusion (91 eyes), postoperative cystoid macular edema (18 eyes), non-infectious uveitis (37 eyes) and other (14 eyes) between July 2013 and April 2020 were reviewed.
Results: After 925 injections were applied to 470 eyes of a total of 383 patients, the eyes were controlled during a mean follow-up of 24 months.